Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03184337 · ClinicalTrials.gov registry record · NA
Women's Lifestyle Balance Study
A NA study of Overweight and PreDiabetes, sponsored by University of California, San Francisco.
- Completed
- Registry status
- NA
- Development phase
- 26
- Enrollment target
- 1
- Study location
NCT03184337: Completed NA study of Overweight and PreDiabetes, sponsored by University of California, San Francisco.
NCT03184337 is a NA study of Overweight and PreDiabetes that has completed, run by University of California, San Francisco. The registered enrollment target is 26 participants, below the 1,323-participant average among 197 other Overweight trials with a reported enrollment target (98% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03184337, a NA study of Overweight and PreDiabetes, has completed, sponsored by University of California, San Francisco.
- COMPLETED
- Registry status
- NA
- Development phase
- 26 participants
- Enrollment target
- 1
- Study location
Study Summary
This pilot study aims to determine whether adding a sleep extension and sleep hygiene intervention to an existing lifestyle improvement program improves its efficacy for weight loss in those at risk for diabetes and cardiovascular disease. Half of the participants will receive the Centers for Disease Control's standard PreventT2 program and half of the participants will receive the same program with an additional sleep intervention.
Primary Outcome
Body mass index is calculated as the participant's body weight divided by the square of their height.
Conditions Studied
Interventions
- BEHAVIORAL CDC's PreventT2 Program
- BEHAVIORAL CDC's PreventT2 Program with Added Sleep Content
Study Locations (1)
California
- University of California, San Francisco - San Francisco
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 26 participants |
| Start Date | 2017-04-24 |
| Est. Completion | 2017-12-31 |
| Phase | NA |
What the finished NCT03184337 record still lists
NCT03184337 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 26 participants, a relatively small participant target, below the 1,323-participant average among 197 other Overweight trials with a reported enrollment target (98% lower).
The record links to 3 conditions, with Overweight appearing as the primary indexed condition, and to 2 interventions - of which CDC's PreventT2 Program is the first listed.
NCT03184337 reports a single indexed study location in California.
Frequently Asked Questions
What is clinical trial NCT03184337 about?
NCT03184337 is a clinical study titled "Women's Lifestyle Balance Study". This pilot study aims to determine whether adding a sleep extension and sleep hygiene intervention to an existing lifestyle improvement program improves its efficacy for weight loss in those at risk for diabetes and cardiovascular disease. Half of the participants will receive the Centers for Diseas...
What is the current status of trial NCT03184337?
This trial is currently completed. It is a NA study. The enrollment target is 26 participants. The study started on 2017-04-24. Estimated completion is 2017-12-31.
What conditions does trial NCT03184337 study?
This clinical trial studies the following conditions: Overweight, PreDiabetes, Metabolic Syndrome.
What interventions are being tested in trial NCT03184337?
The interventions under investigation include: CDC's PreventT2 Program (BEHAVIORAL), CDC's PreventT2 Program with Added Sleep Content (BEHAVIORAL).
Who is sponsoring clinical trial NCT03184337?
This trial is sponsored by University of California, San Francisco, which has 1,713 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03184337 being conducted?
This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Overweight
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT03184337's enrollment target sits among peer trials
26 174th of 197 higher than 23 of 197 other Overweight trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Overweight trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
HealthyTogether: RCT of a Dyadic Weight Management Intervention
RECRUITING · NA
-
Eliminating Severe Maternal Morbidity With Heart Health Doulas Trial
RECRUITING · NA
-
Time Restricted Feeding, Muscle, and Metabolism
RECRUITING · NA
-
Diet Order Effects of Low Fat vs. Low Carb Diets on Body Fat Change
RECRUITING · NA
-
Optimization of Chrononutrition to Reduce the Risk of Disease in Shift Workers
RECRUITING · NA
-
The Influence of Honey-flavored Yogurt on Low-grade Inflammation and Gut Health in Middle to Older Aged Women.
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02646475 · 26 participants · Phase 1
Metabolic Effects of Angiotensin-(1-7)
- NCT03603223 · 26 participants · Phase 2
Pembrolizumab in Treating Participants With Leukoplakia
- NCT04063592 · 26 participants · NA
AMI Construction in Lower Extremity Residual Limbs
- NCT04906460 · 26 participants · Phase 1
Open-label Study of WVE-N531 in Patients With Duchenne Muscular Dystrophy (FORWARD-53)
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI